San Francisco, CA, United States of America

Wendye Robbins

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Wendye Robbins

Introduction

Wendye Robbins, an inventive spirit based in San Francisco, CA, has made a significant contribution to the field of biopharma through her innovative work. With one patent to her name, she focuses on developing advanced methods and compounds that enhance therapeutic efficacy while minimizing side effects for patients.

Latest Patents

Wendye Robbins holds a patent for "Phosphorylated pyrone analogs and methods." This invention pertains to phosphorylated polyphenols, flavonoids, and pyrone analogs. The invention describes methods and compositions designed to modulate the side effects associated with various substances using these phosphorylated compounds. Specifically, her work includes methods that affect blood-tissue barrier (BTB) transporter activity, thereby enhancing the efflux of drugs and other compounds from physiological compartments to the external environment. By coadministering phosphorylated pyrone analogs with therapeutic agents, the invention aims to reduce side effects in patients.

Career Highlights

Wendye Robbins is currently associated with Limerick Biopharma, where her research focuses on innovative therapeutic solutions that address critical health challenges. Her dedication to improving patient outcomes through innovative science is evident in her patent work.

Collaborations

Wendye Robbins collaborates with Ving J Lee, a colleague who plays an important role in her research endeavors. Together, they explore the potential of phosphorylated compounds in their quest for medical advancements that improve drug efficacy and patient safety.

Conclusion

Wendye Robbins exemplifies the spirit of innovation in the biopharmaceutical field. Her patented inventions demonstrate a commitment to improving healthcare outcomes. As she continues to work at Limerick Biopharma, her contributions and collaborations will undoubtedly pave the way for future advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…